Li W - Search Results

1

The Neutrophil to Lymphocyte Ratio May Predict Benefit from Chemotherapy in Lung Cancer.

Liu D, Jin J, Zhang L, Li L, Song J, Li W. Liu D, et al. Among authors: li w, li l. Cell Physiol Biochem. 2018;46(4):1595-1605. doi: 10.1159/000489207. Epub 2018 Apr 20. Cell Physiol Biochem. 2018. PMID: 29694985 Free article.

2

[Co-expression and prognostic significance of hnRNP B1 and CD44 in non-small cell lung cancers].

Deng TB, Li WM, Mo XM, Liu LX, Liu D, Pu R, Chen BJ, Xu L. Deng TB, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;39(5):819-22. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 19024323 Chinese.

3

[Multiparametric flow cytometry analyzes the expressions of immunophenotype CD133, CD34, CD44 in lung cancer naive cells].

Liu D, Li WM, Mo XM, Liu LX, Wang Y, Che GW, Wu Z, Gou JL. Liu D, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;39(5):827-31. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 19024325 Chinese.

4

[Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].

Chen F, Li WM, Wang DM, Gao SS, Bao Y, Chen WB, Liu D. Chen F, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Sep;39(5):832-5. Sichuan Da Xue Xue Bao Yi Xue Ban. 2008. PMID: 19024326 Chinese.

5

[The expression and clinical significance of AKT2, phosphorylated AKT2 in non-small cell lung cancer].

Pu R, Li WM, Liu D, Mo XM, Tang Y, Liu LX, Chen BJ. Pu R, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Jul;41(4):586-9. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 20848774 Chinese.

6

[A cross-sectional investigation on risk factors of lung cancer for residents over 40 years old in Chengdu, Sichuan Province, China].

Chen B, Li W, Jia Y, Guo N, Liu D, Tang X, Wang Q, Xiao L. Chen B, et al. Among authors: li w. Zhongguo Fei Ai Za Zhi. 2010 Nov;13(11):1021-6. doi: 10.3779/j.issn.1009-3419.2010.11.05. Zhongguo Fei Ai Za Zhi. 2010. PMID: 21081041 Free PMC article. Chinese.

7

Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma.

Liu D, Huang Y, Chen B, Zeng J, Guo N, Zhang S, Liu L, Xu H, Mo X, Li W. Liu D, et al. Among authors: li w. Cancer. 2011 Aug 15;117(16):3763-73. doi: 10.1002/cncr.25959. Epub 2011 Mar 8. Cancer. 2011. PMID: 21387259 Free article.

8

Down-regulation of JAK1 by RNA interference inhibits growth of the lung cancer cell line A549 and interferes with the PI3K/mTOR pathway.

Liu D, Huang Y, Zeng J, Chen B, Huang N, Guo N, Liu L, Xu H, Mo X, Li W. Liu D, et al. Among authors: li w. J Cancer Res Clin Oncol. 2011 Nov;137(11):1629-40. doi: 10.1007/s00432-011-1037-6. Epub 2011 Aug 23. J Cancer Res Clin Oncol. 2011. PMID: 21861134

9

Loss of Bad expression confers poor prognosis in non-small cell lung cancer.

Huang Y, Liu D, Chen B, Zeng J, Wang L, Zhang S, Mo X, Li W. Huang Y, et al. Among authors: li w. Med Oncol. 2012 Sep;29(3):1648-55. doi: 10.1007/s12032-011-0060-4. Epub 2011 Sep 15. Med Oncol. 2012. PMID: 21918885

10

Overexpression of Bcl-2-associated death inhibits A549 cell growth in vitro and in vivo.

Huang N, Zhu J, Liu D, Li YL, Chen BJ, He YQ, Liu K, Mo XM, Li WM. Huang N, et al. Cancer Biother Radiopharm. 2012 Mar;27(2):164-8. doi: 10.1089/cbr.2011.1018. Epub 2011 Oct 19. Cancer Biother Radiopharm. 2012. PMID: 22011203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81,951 results

Search Page

Filters